Can very high level of D-dimer exclusively predict the presence of thromboembolic diseases?

نویسنده

  • Chao-Hung Ho
چکیده

BACKGROUND D-dimer quantitative test is mainly used to rule out the presence of thromboembolic diseases (TEDs). Whether very high D-dimer (100 times above the cutoff point) can exclusively indicate the presence of TED should be known. METHODS D-dimer was detected by a quantitative immunoturbidimetric assay. The normal value is 0.2-0.7 mg/L fibrinogen equivalent units (FEUs). During the year of 2009, 1,053 D-dimer tests were performed. We analyzed the results of these patients to find out the causes of very high D-dimer. RESULTS The mean value of D-dimer in the 1,053 tests was 8.56 mg/L FEU, ranging from <0.2 mg/L to 563.2 mg/L FEU. Of them, 28 samples from 21 patients had very high D-dimer value: >50 mg/L FEU. Of the 21 patients, 9 (43%) had TED, 1 had suspected TED, but not proved by computed tomographic (CT) angiogram, 3 had massive gastrointestinal or other site bleeding, 3 patients had cardiac arrest with samples taken immediately after recovery from cardiopulmonary resuscitation (CPR), 2 had sepsis with disseminated intravascular coagulation (DIC), 1 had postpartum hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome with acute pulmonary edema and renal failure, 1 had multiple traumatic injury, and 1 received thrombolytic therapy. CONCLUSION Although TED was the most frequently seen disorder in patients with very high D-dimer value, very high D-dimer was not necessary exclusively the marker of TED. Other disorders such as massive bleeding, status post CPR, sepsis with DIC, multiple traumatic injuries, hyperfibrinolysis and HELLP syndrome can also have very high D-dimer.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.

OBJECTIVES The aim of the present study was to evaluate whether elevated D-dimer levels can predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy. BACKGROUND Atrial fibrillation is associated with hemostatic abnormalities even during oral anticoagulant therapy. D-dimer levels reflect a pro-thrombogenic state and thus...

متن کامل

Plasma Fibrinogen and D-dimer in Children With Sepsis: A Single-center Experience

Background & Objectives:  In sepsis, enhanced fibrin formation, impaired fibrin degradation, and intravascular fibrin deposition lead to a prothrombotic state. The current study aimed at measuring various coagulation parameters to predict an early marker for disseminated intravascular coagulation (DIC). Methods: The current prospective s...

متن کامل

Evaluation of Correlation between D-dimer Levels with Disease Severity in Patients with Covid-19 Referred to Hamedan Besat Hospital in 2021-2022

Introduction: The Covid-19 virus affects the hemostasis system in infected people by causing thrombosis and it increases the level of D_dimer. This study was designed and conducted for the evaluation of correlation between D-dimer levels with disease severity in patients with Covid-19 referred to Hamedan Besat hospital. Methods and Materials: 366 patients with Covid-19 referred to Besat Hospit...

متن کامل

The Effect of Preanalytical, Analytical, and Postanalytical Variables on D-dimer Measurement

D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of activation of coagulation and fibrinolysis, and it is routinely used for ruling out venous thromboembolism (VTE). D-dimer is increasingly used to assess the risk of VTE recurrence and to help define the uoptimal duration of anticoa...

متن کامل

Risk Factors of Deep Vein Thrombosis in Cancer Patients

Background: Venous thromboembolism (VTE) is a significant complication in cancer patients which was found in 4-20% of the patients. This study was aimed to evaluate risk factors of deep vein thrombosis (DVT) in cancer patients in an oncology center in Indonesia.  Methods: This was a retrospective cohort study. Data were obtained from medical records of adult cancer patients with DVT referring ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of the Chinese Medical Association : JCMA

دوره 74 4  شماره 

صفحات  -

تاریخ انتشار 2011